Analyzes variant detection affecting workflow updates in germline sequencing, suggesting validation importance.
Background: Bioinformatics pipelines influence putative false-positive calls (technical artifacts) in clinical germline next-generation sequencing; however, the impact of workflow updates on variant detection behavior in clinical panels remains unclear.Methods: We analyzed 114 clinical samples that were sequenced using a 4,815-gene panel.Starting with identical FASTQ files, we compared a legacy workflow (Burrows-Wheeler aligner [BWA] aln+Genome Analysis Toolkit [GATK] UnifiedGenotyper) and a modern workflow (BWA-maximal exact matches [MEM]+GATK HaplotypeCaller), aligners under a fixed caller, and callers under a fixed aligner.Putative technical artifacts were defined as recurrent variants (≥10/114 samples) that were rare (gnomAD minor allele frequency <0.001) or absent from gnomAD and the Korean reference database (K1055E).Concordance with the GIAB HG001 (NA12878) truth set was evaluated within the panel target regions that intersected with GIAB high-confidence regions.Results: The legacy workflow produced 1,691 recurrent rare/novel variants that were not reproduced by the modern workflow.The transition/ transversion ratio shifted from 3.097 to 2.393 for the same TruSight One target design, indicating workflow-dependent differences in the single nucleotide variant spectrum.Indel call counts increased 7.37-fold, reflecting a change in call yield rather than a direct improvement in accuracy.In controlled comparisons, BWA aln and FreeBayes generated more recurrent rare/novel calls than BWA-MEM/Bowtie2 and HaplotypeCaller.In the GIAB benchmark, the pipelines showed comparable concordance with a slightly higher single nucleotide polymorphism concordance in the legacy workflow and increased indel detection in the modern workflow.Conclusions: Updating the aligner-caller workflow markedly reduced recurrent rare/novel calls, consistent with technical artifacts in clinical germline panel testing.This finding highlights the importance of validating workflow updates.
No takes yet. Share an insight, caveat, or question.
Jaewoong Lee (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: